以快速增长的23.5B市场为目标的AI开发的新过敏治疗专利。 Cosmos Health patents new AI-developed allergy treatment, targeting a fast-growing $23.5B market.

Cosmos Health公司已申请一项专利,用于使用AI药物再利用技术开发的过敏炎新治疗。 Cosmos Health has filed a patent for a new treatment for allergic inflammation, developed with AI drug repurposing technology. 这项应用程序与Cloudpharm和希腊国家研究基金会合作, 采用创新方法针对炎症途径. The application, made in partnership with Cloudpharm and the National Hellenic Research Foundation, uses innovative methods to target inflammatory pathways. 全球过敏治疗市场目前的价值为235亿美元,预计到2033年将增长到370亿美元。 The global market for allergy treatments is currently valued at $23.5 billion and expected to grow to $37 billion by 2033.